Ben Hirschler
Articles RSS
Position: Senior Correspondent
Ben is responsible for coverage of pharmaceuticals, healthcare and science in Europe. He has been with Reuters since 1987, starting as a commodities reporter in London before moving to Amsterdam, covering business and general news. In the mid-1990s, he was based in Johannesburg, writing about the economic challenges facing post-apartheid South Africa. He returned to London to cover emerging markets and UK companies before moving into his current position.
Blog Posts
Swine flu sales: windfall or hard work?
Swine flu is turning out to be a sales bonanza for drug companies - just don't call it a windfall, says GlaxoSmithKline. Full Article | Comments [2]
Health reform...big in Europe too
U.S. healthcare reform is top of everybody's agenda right now - but Barack Obama isn't the only government leader chasing a new deal. Full Article
Live blog at Reuters Health Summit
A dozen Reuters reporters are covering the annual Reuters Health Summit in New York, featuring speakers from the world's leading healthcare companies, including Pfizer, GlaxoSmithKline, Merck, Novartis, AstraZeneca, Novo Nordisk and Eli Lilly, plus top insurers and the commissioner of the Food and Drug Administration. Full Article | Comments [2]
